Last updated 20201009 #Covid19 Catchall post
20201009, Stat News, “7 looming questions about the rollout of a Covid-19 vaccine” (many VERY insightful questions #mustRead)
- How do you define high-risk health workers? Essential workers?
- High-risk medical conditions push you to the front of the vaccine line. How do you prove you have them when you get there?
- How do you vaccinate special populations when there are little or no data on how the vaccines work for them? [K: children, pregnant people]
- How widely can Pfizer and BioNTech’s vaccine be used, given its taxing storage requirements? [K: “Pfizer and BioNTech’s candidate, which uses messenger RNA technology, must be shipped and stored at -70 Celsius.”]
- How will Pfizer and BioNTech’s ordering system affect the potential rollout of its vaccine?
- With air travel slowed, can vaccines get where they need to go quickly?
- How can officials keep a highly coveted resource safe from theft — and prevent counterfeits?
Above Pix Full Credit: NIAID (NIH) Flickr post //Novel Coronavirus SARS-CoV-2
This transmission electron microscope image shows SARS-CoV-2—also known as 2019-nCoV, the virus that causes COVID-19—isolated from a patient in the U.S. Virus particles are shown emerging from the surface of cells cultured in the lab. The spikes on the outer edge of the virus particles give coronaviruses their name, crown-like. Image captured and colorized at NIAID’s Rocky Mountain Laboratories (RML) in Hamilton, Montana. Credit: NIAID //